Target Discovery - Market Opportunities

Home

Main Menu

Home
About TDI
Isonostic™ Products
Corporate Communications
Careers
Contact Us
Site Map

PDF Viewer

Adobe Reader 6.0 or higher is required to view our PDF documents.

Partnered Programs

Outside of our cancer focus, TDI works with companies to develop Isonostic™ assays for other diseases where protein isoforms are known or suspected to be useful biomarkers. The development of assays to determine patient-specific response profiles relative to drug efficacy or toxicology (Theranostics) is an area of partnering interest.

Learn more about Theranostics
Learn more about Partnered Programs